Edition:
United Kingdom

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

16.69USD
8:55pm BST
Change (% chg)

$0.19 (+1.15%)
Prev Close
$16.50
Open
$16.48
Day's High
$16.73
Day's Low
$16.12
Volume
73,246
Avg. Vol
328,405
52-wk High
$32.32
52-wk Low
$9.87

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -4.18 -- --
ROI: -49.45 8.91 13.83
ROE: -52.35 10.06 15.25

Earnings vs. Estimates